Literature DB >> 15850071

Candidal arthritis after complete treatment of systemic candidiasis.

Wen-Bin Hsieh1, Cheung Leung.   

Abstract

Over the last few decades, the incidence of invasive candidal infections in neonatal intensive care units has increased dramatically. Various complications, such as arthritis, endocarditis, meningitis, and endophthalmitis, have been reviewed. We present the case of a premature infant with systemic candidemia. Arthritis was discovered 6 months after completion of amphotericin B therapy, and was successfully treated with oral fluconazole for 6 weeks. We conclude that long-term follow-up is particularly important in patients with treated candidemia. To prevent complications, prolonged treatment with high-dose amphotericin B is suggested for systemic fungal infection, and oral fluconazole is an effective alternative for candidal arthritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850071     DOI: 10.1016/S1726-4901(09)70248-5

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

Review 1.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

2.  Primary Candida guilliermondii Infection of the Knee in a Patient without Predisposing Factors.

Authors:  Gun Woo Lee; Tae-Hun Kim; Jung-Hwan Son
Journal:  Case Rep Med       Date:  2012-02-28

Review 3.  Safety of fluconazole in paediatrics: a systematic review.

Authors:  Oluwaseun Egunsola; Abiodun Adefurin; Apostolos Fakis; Evelyne Jacqz-Aigrain; Imti Choonara; Helen Sammons
Journal:  Eur J Clin Pharmacol       Date:  2013-01-17       Impact factor: 2.953

4.  Neonatal Candida arthritis.

Authors:  Saurabh Sharma; Kapil Gangwal
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.